Presentationhttps://youtu.be/Oto75D6skAw
Here is the presentation . The histological results look really impressive. Retail investor will not understand the significance. The presentation does not give clinical endpoint data or number of patients in the trial. But the presentation does show it works and validates it in more than one patient. I think management is holding more details to their chest. No details or updates from the phenomenology results from first patient are mentioned . They do not say if similar results occur in other patients but from the histological slides it looks it like that way.
canada did management reach out and console you ? The pouch works and is safe , produces insulin in multiple patients which is great news . I hope the company releases more endpoint data.